To further expand trading opportunities and enhance your Futures trading experience, MEXC will launch NEM, SLB, PYPL and TEM USDT-M Stock Futures on the Futures market. This new listing offers a flexible and efficient way to gain exposure to one of the most prominent U.S. equities. Futures trading will be available immediately upon listing, with Futures Grid Bot strategies available within 5 minutes of listing.

NEM: Newmont Corporation engages in the production and exploration of gold. It also explores for copper, silver, zinc, and lead. The company has operations and/or assets in the United States, Canada, Mexico, Dominican Republic, Peru, Suriname, Argentina, Chile, Australia, and Ghana. As of December 31, 2021, it had proven and probable gold reserves of 92.8 million ounces and land position of 62,800 square kilometers. The company was founded in 1916 and is headquartered in Denver, Colorado.

SLB: SLB engages in global oilfield technology services and equipment supply. The business covers providing formation evaluation, well drilling direction, cementing and completion, and stimulation fracturing services to oil and gas exploration enterprises. Additionally, the company develops digital software systems for monitoring oilfield extraction. The company does not own the oil and gas assets themselves, but dispatches professional engineering teams equipped with precision detection hardware to various onshore and deepwater drilling platforms, charging technical and equipment service fees on a per-project basis.

PYPL: PYPLon is the Ondo Tokenized version of PayPal, giving tokenholders economic exposure similar to holding PYPL and reinvesting any dividends. Ondo tokenized stocks enable non-US retail and institutional users around the world to instantly mint and redeem tokenized U.S. stocks and ETFs, 24 hours a day, five days a week with full access to traditional exchange liquidity. Additional restrictions apply. Learn more at ondo.finance/global-markets.

TEM: Tempus AI, Inc. develops artificial intelligence applications and genomic sequencing pipelines engineered for precision medicine and clinical oncology data aggregation. By constructing an extensive database of de-identified clinical records mapped directly to next-generation genomic sequencing (NGS), the firm monetizes via diagnostic sequencing fees for hospitals and high-value healthcare data analytics licensing for global pharmaceutical R&D labs.

Enjoy 0 trading fees on the Stock Futures for a limited time!

This fee update only applies to select users in specific regions. Please check your account's fee page or trading page for the latest rates.

👉 Learn more about Stock Futures on MEXC

• Corporate actions (e.g., dividends, stock splits, reverse splits) may cause sharp price movements. Depending on market conditions, the platform may implement measures including early settlement or position adjustments. Users should monitor relevant announcements and manage risks to avoid unexpected losses.

• U.S. stocks may trigger a circuit breaker due to market conditions. If triggered, trading will be halted and orders cannot be executed. No liquidation will occur, and existing orders can still be canceled. Please monitor the market, manage your positions, and refer to the official circuit breaker announcement for details.

• Availability of Stock Futures may vary by region due to regulatory restrictions. Certain jurisdictions may not support these products. Please refer to the User Agreement for full details.

• MEXC reserves the right to adjust the list of supported regions at any time based on operational and compliance considerations.